US Patent Issued to ARENA PHARMACEUTICALS on June 2 for "Compositions comprising PGI2-receptor agonists and processes for the preparation thereof" (California, Washington Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,771, issued on June 2, was assigned to ARENA PHARMACEUTICALS INC. (New York).

"Compositions comprising PGI2-receptor agonists and processes for the preparation thereof" was invented by Zezhi Jesse Shao (San Diego), Raizza Berania Florida (Escondido, Calif.), Ching-Yuan Li (San Diego) and Lee Alani Selvey (Longview, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein in some embodiments are pharmaceutical compositions comprising a prostacyclin (PGI2) receptor agonist selected from 2-(((1r,4r)-4-(((4-chlorophenyl)(phenyl)carbamoyloxy)methyl)cyclohexyl)methoxy)acetic acid (Compound 1) and pharmaceutically acceptable salts, solvates, and...